New Paper Published on Fatigue and Sleep Assessment through Digital Wearables

Our newly published research presents results on using wearable sensing technology to assess fatigue and sleep in patients with chronic diseases. The article provides clinicians with insights on monitoring patients in the natural everyday settings of a patient’s daily life. In the future, wearable sensors could capture the effect the disease has on the patient’s […]

Data Standards in IDEA-FAST

One of the main goals of the IDEA-FAST project is to identify novel digital measures for fatigue and sleep disturbances. To achieve this goal, a large amount of data, including clinical data (e.g., demographic data of the recruited patients) and device data (e.g., data collected by sensors and wearable devices for monitoring fatigue, sleep and […]

Sleepless society – The socioeconomic burden of sleep disturbances

“Being up with the lark”, “the early bird catches the worm”, or “being a night owl” – these phrases are all familiar. A work-focused and digitally connected culture produces the notion of constant availability and the pressure of maximizing time, even if this comes at the expense of our sleep.   Looking at sleep patterns, there is a trend towards shorter […]

Health and remote monitoring

There is no doubt that the global pandemic caused by COVID-19 has impacted all sectors of society and the whole population, especially citizens affected by chronic diseases. In this article we would like emphasise the impact that the pandemic had (and continues to have) on people affected by Parkinson’s, as well as on the opportunities […]

The IDEA-FAST feasibility study – Finding the most promising digital measures for sleep disturbances and fatigue

The aim of the feasibility study, which started in July this year, is to gather information on a variety of potential digital measures captured with different devices and their ability of reflecting sleep disturbances or fatigue. Apart from comparing data between different measures from patients with neurodegenerative disorders or immune-mediated inflammatory diseases as well as […]